Min-Huei Huang

Title: Min-Huei Huang: Innovator in Tumor Imaging and Therapy

Introduction

Min-Huei Huang is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of pharmaceutical compositions, particularly in tumor imaging and therapy. His innovative work focuses on developing compounds that enhance the specificity of treatments for cancer.

Latest Patents

Min-Huei Huang holds a patent for a compound and pharmaceutical composition designed for tumor imaging and tumor therapy. The patent describes a compound represented by formula (I), where R and R' independently represent hydrogen, O—R, or S—R. At least one of R and R' is O—R or S—R, and R and R' are independently a C to C alkyl group. This alkyl group can be non-substituted or substituted with various functional groups, including —OH, —NH, halogen, ester, ether, and carboxylic acid, with M being a metal or a metal-containing compound. This compound has demonstrated higher specificity to tumor cells, making it suitable for carrying anti-cancer drugs and/or nuclear imaging agents.

Career Highlights

Min-Huei Huang is associated with Seecure Taiwan Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the area of cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Wei-Chung Chang and Kun-Hsin Lee, to further enhance the impact of his research and innovations.

Conclusion

Min-Huei Huang's contributions to tumor imaging and therapy exemplify the importance of innovation in the fight against cancer. His patented compound represents a significant advancement in targeted cancer treatment, showcasing his dedication to improving patient outcomes.